estriol has been researched along with Syndrome in 18 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this prospective comparative cohort study was to establish the effectiveness and safety of Erbium:YAG (Er:YAG) laser treatment for genitourinary syndrome of menopause and to compare it with an established topical estriol treatment." | 9.24 | Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. ( Brandi, H; Gaspar, A; Gomez, V; Luque, D, 2017) |
| "The objective of this prospective comparative cohort study was to establish the effectiveness and safety of Erbium:YAG (Er:YAG) laser treatment for genitourinary syndrome of menopause and to compare it with an established topical estriol treatment." | 5.24 | Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. ( Brandi, H; Gaspar, A; Gomez, V; Luque, D, 2017) |
| "Information on maternal age and maternal serum alpha-fetoprotein, unconjugated oestriol (uE3), and human chorionic gonadotrophin (hCG) levels was used to investigate retrospectively the effect of estimating Edward's syndrome risk in women having multi-marker screening for Down's syndrome." | 3.68 | Expanding multiple marker screening for Down's syndrome to include Edward's syndrome. ( Barkai, G; Chaki, R; Cuckle, H; Goldman, B; Ries, L; Zer, T, 1993) |
| "The syndrome is underreported and undertreated in Norway." | 1.28 | [Urogenital estrogen deficiency syndrome. Investigation and treatment with special reference to hormone substitution]. ( Eriksen, BC; Hunskår, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaspar, A | 1 |
| Brandi, H | 1 |
| Gomez, V | 1 |
| Luque, D | 1 |
| Langlois, S | 1 |
| Armstrong, L | 1 |
| Gall, K | 1 |
| Hulait, G | 1 |
| Livingston, J | 1 |
| Nelson, T | 1 |
| Power, P | 1 |
| Pugash, D | 1 |
| Siciliano, D | 1 |
| Steinraths, M | 1 |
| Mattman, A | 1 |
| USHIJIMA, Y | 1 |
| Cragun, DL | 1 |
| Trumpy, SK | 1 |
| Shackleton, CH | 1 |
| Kelley, RI | 1 |
| Leslie, ND | 1 |
| Mulrooney, NP | 1 |
| Hopkin, RJ | 1 |
| Begleiter, ML | 1 |
| Lund, MM | 1 |
| Atherton, AM | 1 |
| Buchholz, JD | 1 |
| Ardinger, HH | 1 |
| Kretova, NE | 1 |
| Neverov, IV | 1 |
| Novikov, VT | 1 |
| Kozlova, RI | 1 |
| Spinova, RP | 1 |
| Barkai, G | 1 |
| Goldman, B | 1 |
| Ries, L | 1 |
| Chaki, R | 1 |
| Zer, T | 1 |
| Cuckle, H | 2 |
| Moroz, C | 1 |
| Maymon, R | 1 |
| Jauniaux, E | 1 |
| Traub, L | 1 |
| Benn, PA | 1 |
| Leo, MV | 1 |
| Rodis, JF | 1 |
| Beazoglou, T | 1 |
| Collins, R | 1 |
| Horne, D | 1 |
| Witters, I | 1 |
| Legius, E | 1 |
| Devriendt, K | 1 |
| Moerman, P | 1 |
| Van Schoubroeck, D | 1 |
| Van Assche, A | 1 |
| Fryns, JP | 1 |
| Ansari, AH | 1 |
| Fuller, DG | 1 |
| Granat, M | 1 |
| Sharf, M | 1 |
| Diengott, D | 1 |
| Spindel, A | 1 |
| Kahana, L | 1 |
| Elrad, H | 1 |
| Asch, RH | 1 |
| Zuo, WL | 1 |
| Garcia, M | 1 |
| Ramzy, I | 1 |
| Laufe, L | 1 |
| Rojas, FP | 1 |
| Rachev, E | 1 |
| Katsarova, M | 1 |
| Eriksen, BC | 1 |
| Hunskår, S | 1 |
| Hobbins, JC | 1 |
| Goldstein, L | 1 |
| Hofschild, J | 1 |
| Beischer, NA | 1 |
| Ratten, GJ | 1 |
| Fortune, DW | 1 |
| Macafee, J | 1 |
| Heuser, HP | 1 |
| Staemmler, HJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus[NCT03063684] | 16 participants (Actual) | Interventional | 2017-09-01 | Completed | |||
| Effectiveness of C02 Microfractionated Laser in Conjunction With Topical Regenerative Therapy in the Management of Vulvo-vaginal Atrophy in Patients With a History of Breast Cancer. Randomized Experimental and Comparative Study.[NCT05585476] | 98 participants (Anticipated) | Interventional | 2022-12-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for estriol and Syndrome
| Article | Year |
|---|---|
Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
Topics: Administration, Topical; Estriol; Female; Female Urogenital Diseases; Humans; Laser Therapy; Lasers, | 2017 |
Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
Topics: Administration, Topical; Estriol; Female; Female Urogenital Diseases; Humans; Laser Therapy; Lasers, | 2017 |
Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
Topics: Administration, Topical; Estriol; Female; Female Urogenital Diseases; Humans; Laser Therapy; Lasers, | 2017 |
Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
Topics: Administration, Topical; Estriol; Female; Female Urogenital Diseases; Humans; Laser Therapy; Lasers, | 2017 |
[Replacement therapy with Estrofem in the postcastration syndrome].
Topics: Adolescent; Adult; Drug Combinations; Estradiol; Estriol; Female; Humans; Middle Aged; Ovariectomy; | 1991 |
16 other studies available for estriol and Syndrome
| Article | Year |
|---|---|
Steroid sulfatase deficiency and contiguous gene deletion syndrome amongst pregnant patients with low serum unconjugated estriols.
Topics: British Columbia; DNA Mutational Analysis; Estriol; Female; Gene Deletion; Genetic Diseases, Inborn; | 2009 |
[CLINICAL EXPERIENCES WITH ESTRIOL TRIPROPIONATE ON CLIMACTERIC DISORDERS].
Topics: Climacteric; Drug Therapy; Estriol; Humans; Syndrome | 1964 |
Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Abnormalities, Multiple; Adult; Child, Preschool; Craniosynostoses; Es | 2004 |
Maternal serum screening and 22q11.2 deletion syndrome.
Topics: Abnormalities, Multiple; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human | 2007 |
[Effect of estrogens on lipid metabolism in patients with climacteric myocardiodystrophy alone and associated with ischemic heart disease].
Topics: Cardiomyopathies; Climacteric; Coronary Disease; Drug Evaluation; Electrocardiography; Estriol; Fema | 1984 |
Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1993 |
Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin, beta Subunit, Human; Chromosomes, Human, Pair 18; Down S | 2000 |
Maternal serum screening for fetal trisomy 18: a comparison of fixed cutoff and patient-specific risk protocols.
Topics: Abnormalities, Multiple; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair | 1999 |
Pregnancy outcome and long term prognosis in 868 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype.
Topics: Abnormalities, Multiple; Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Congenita | 2001 |
Urinary estriol for assessment of fetoplacental function.
Topics: Adolescent; Adult; Congenital Abnormalities; Erythroblastosis, Fetal; Estriol; Female; Heart Disease | 1977 |
Further investigation on the predictive value of human placental lactogen in high-risk pregnancies.
Topics: Adult; Estriol; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Infant, Sma | 1977 |
Intrauterine release of oestriol in castrated rhesus monkeys induces local but not peripheral oestrogenic effects: a possible approach for the treatment and prevention of Asherman's syndrome.
Topics: Animals; Endometrium; Estradiol; Estriol; Estrogens; Female; Follicle Stimulating Hormone; Intrauter | 1991 |
[Urogenital estrogen deficiency syndrome. Investigation and treatment with special reference to hormone substitution].
Topics: Aged; Atrophy; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Female Urogenital Diseases; | 1991 |
Value of HCS determinations in management of prolonged pregnancy.
Topics: Estradiol; Estriol; Estrone; Female; Gestational Age; Humans; Immunodiffusion; Infant, Newborn; Plac | 1974 |
Obstetric complications when the fetus has Potter's syndrome. II. Fetoplacental function.
Topics: Adult; Estriol; Facial Expression; Female; Humans; Kidney; Nose Deformities, Acquired; Pregnancy; Pr | 1973 |
Histological investigations into the effect of oestriol succinate on the corpus uteri in postmenopausal women.
Topics: Aged; Capillaries; Dose-Response Relationship, Drug; Endometrium; Estriol; Female; Humans; Menopause | 1973 |